Codexis to Hold 2016 Fourth Quarter and Full Year Conference Call on March 9
March 02, 2017 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2016 financial...
Codexis to Offer High-Performance Enzymes for Diagnostics Markets
January 06, 2017 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will offer high-performance enzymes for customers using...
Codexis to Commercially Supply Proprietary Enzyme to Tate & Lyle
December 06, 2016 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 06, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, today announced that it has entered into an exclusive agreement with Tate...
Codexis to Present at the 7th Annual Craig-Hallum Alpha Select Conference
November 10, 2016 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at the 7th Annual Craig-Hallum...
Codexis Reports Financial Results for the Third Quarter of 2016
November 08, 2016 16:05 ET
|
Codexis, Inc.
Revenues of $14.9 million driven by core biocatalyst product sales increase of 123%and include $8.0 million milestone revenue from Merck Conference call begins at 4:30 p.m. Eastern time today ...
Codexis to Hold 2016 Third Quarter Conference Call on November 8
November 01, 2016 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report third quarter 2016 financial results...
Michael Aldridge Joins Codexis as Senior Vice President, Corporate & Strategic Development
October 17, 2016 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 17, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that Michael Aldridge has joined the company as Senior Vice...
Codexis Completes Transfer of CodeEvolver® Technology to Merck
October 05, 2016 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announced the completion of the second and final phase in the transfer...
Codexis to Present at September Investment Conferences
September 06, 2016 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment...
Codexis Reports Financial Results for the Second Quarter of 2016
August 09, 2016 16:05 ET
|
Codexis, Inc.
Net income reaches $2.2 million; revenues of $16.0 million include milestone payments from GSK and a major biopharmaceutical company, and 62% growth in core biocatalyst product sales Conference...